Isoxazole-Derived Amino Acids Are Bromodomain-Binding Acetyl-Lysine Mimics: Incorporation into Histone H4 Peptides and Histone H3
Overview
Authors
Affiliations
A range of isoxazole-containing amino acids was synthesized that displaced acetyl-lysine-containing peptides from the BAZ2A, BRD4(1), and BRD9 bromodomains. Three of these amino acids were incorporated into a histone H4-mimicking peptide and their affinity for BRD4(1) was assessed. Affinities of the isoxazole-containing peptides are comparable to those of a hyperacetylated histone H4-mimicking cognate peptide, and demonstrated a dependence on the position at which the unnatural residue was incorporated. An isoxazole-based alkylating agent was developed to selectively alkylate cysteine residues in situ. Selective monoalkylation of a histone H4-mimicking peptide, containing a lysine to cysteine residue substitution (K12C), resulted in acetyl-lysine mimic incorporation, with high affinity for the BRD4 bromodomain. The same technology was used to alkylate a K18C mutant of histone H3.
Schiedel M, McArdle D, Padalino G, Chan A, Forde-Thomas J, McDonough M J Med Chem. 2023; 66(23):15801-15822.
PMID: 38048437 PMC: 10726355. DOI: 10.1021/acs.jmedchem.3c01321.
Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery.
Russell C, Carter J, Borgia J, Bush J, Calderon F, Gabarro R ACS Infect Dis. 2023; 9(11):2340-2357.
PMID: 37906637 PMC: 10644352. DOI: 10.1021/acsinfecdis.3c00431.
Mutate and Conjugate: A Method to Enable Rapid In-Cell Target Validation.
Thomas A, Serafini M, Grant E, Coombs E, Bluck J, Schiedel M ACS Chem Biol. 2023; 18(11):2405-2417.
PMID: 37874862 PMC: 10660337. DOI: 10.1021/acschembio.3c00437.
Sekirnik A, Reynolds J, See L, Bluck J, Scorah A, Tallant C ACS Chem Biol. 2022; 17(10):2753-2768.
PMID: 36098557 PMC: 9594046. DOI: 10.1021/acschembio.2c00266.
Bruzguliene J, Rackauskiene G, Bieliauskas A, Milisiunaite V, Dagiliene M, Matuleviciute G Beilstein J Org Chem. 2022; 18:102-109.
PMID: 35096179 PMC: 8767561. DOI: 10.3762/bjoc.18.11.